Bioactive Wound Dressings Market to Reach $2.6 Billion by 2036
The bioactive wound dressings market is projected to grow from USD 1 billion in 2026 to USD 2.6 billion by 2036, driven by chronic wound prevalence and innovation in collagen and ECM technologies.
This matters because chronic wounds affect millions globally, leading to severe complications and high healthcare costs. Bioactive dressings accelerate healing and reduce infections, improving patient outcomes and lowering long-term treatment expenses. As the population ages and diabetes rises, these advanced materials become critical for effective wound management.
